
Top Stories for Week of July 13, 2020
Fierce US surge adds over one million new coronavirus cases the past four weeks, ending months of declining national death totals. Since the first US case of the new coronavirus… Read more »
Fierce US surge adds over one million new coronavirus cases the past four weeks, ending months of declining national death totals. Since the first US case of the new coronavirus… Read more »
Trump Administration sets coronavirus conditions to reviving US economy. Vice President Mike Pence and one of the top US health officials said regenerating the country’s economy hinges on the government… Read more »
The News: A high-salt diet may negatively affect cognitive function by causing a deficiency of the compound nitric oxide, which is vital for maintaining vascular health in the brain, according… Read more »
The News: Researchers report that a quick eye exam might one day allow eye doctors to check up on both your eyeglasses prescription and your brain health. A study of… Read more »
The News: Possibly to the chagrin of some men, a new study finds that women tend to have more youthful brains than their male counterparts–at least when it comes to… Read more »
The News: A blood plasma replacement therapy from Spanish company Grifols SA (Barcelona) reduced cognitive decline by 61% in patients with moderate Alzheimer’s disease compared with placebo, Labiotech.eu reports. The… Read more »
The News: New evidence suggests that atrial fibrillation, in which the heart has an irregular beat, is linked to an increased risk of dementia. An irregular heartbeat speeds up the… Read more »
The News: Testing how well people remember past events in their lives could help medical professionals make early predictions about who is at risk for developing Alzheimer’s disease (AD), according… Read more »
The News: After decades of prominent failures, hope arose for a drug to slow the progression of Alzheimer’s disease (AD). After heightening expectations recently, Eisai Co. Ltd. (Tokyo) and Biogen… Read more »
The News: BioArctic AB, based in Stockholm, said it has clinical results showing its antibody treatment that targets amyloid plaques, a hallmark of Alzheimer’s disease, can slow the disease’s progression. The trial… Read more »